All I know is this, they need to get NGIO listed o
Post# of 36566
(Total Views: 263)
Posted On: 05/27/2021 10:29:21 AM
All I know is this, they need to get NGIO listed once and for all. They need to be upfront with what is going on with revenue, what is going on with the businesses they said they would be providing updates on and be on time doing it.
Shareholders have been waiting and I know Generex / NGIO have businesses to run, but they keep changing the game with and for several years now, we have been waiting for Generex to get listed, then NGIO to get listed, for products to come on line, for really everything to happen. We are still waiting. Now it looks like things are happening, but once again, silence descends on Generex / NGIO when we should be hearing things, especially when they should be providing more updates.
And sheeze, can they finally put this IND in to the FDA. That's a horse that has been beaten for months and we are still waiting on it.
With the FDA possibly changing the game here in the US with how the vaccines will be handled, it is more important to know how this is affecting or will affect Generex / NGIO. This is something they need to tell their shareholders and future investors.
It just can't be business as usual anymore on anything.
Shareholders have been waiting and I know Generex / NGIO have businesses to run, but they keep changing the game with and for several years now, we have been waiting for Generex to get listed, then NGIO to get listed, for products to come on line, for really everything to happen. We are still waiting. Now it looks like things are happening, but once again, silence descends on Generex / NGIO when we should be hearing things, especially when they should be providing more updates.
And sheeze, can they finally put this IND in to the FDA. That's a horse that has been beaten for months and we are still waiting on it.
With the FDA possibly changing the game here in the US with how the vaccines will be handled, it is more important to know how this is affecting or will affect Generex / NGIO. This is something they need to tell their shareholders and future investors.
It just can't be business as usual anymore on anything.
(2)
(0)